344 related articles for article (PubMed ID: 19532051)
1. Early antiretroviral therapy: the role of cohorts.
Sabin CA
Curr Opin HIV AIDS; 2009 May; 4(3):200-5. PubMed ID: 19532051
[TBL] [Abstract][Full Text] [Related]
2. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
3. Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation.
Grulich AE
Curr Opin HIV AIDS; 2009 May; 4(3):183-7. PubMed ID: 19532048
[TBL] [Abstract][Full Text] [Related]
4. Renal disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
Szczech LA
Curr Opin HIV AIDS; 2009 May; 4(3):167-70. PubMed ID: 19532045
[TBL] [Abstract][Full Text] [Related]
5. When to start antiretroviral therapy?
Wilkin TJ; Gulick RM
Clin Infect Dis; 2008 Dec; 47(12):1580-6. PubMed ID: 18990069
[TBL] [Abstract][Full Text] [Related]
6. Neurological disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
Wright EJ
Curr Opin HIV AIDS; 2009 Sep; 4(5):447-52. PubMed ID: 20048710
[TBL] [Abstract][Full Text] [Related]
7. When to start antiretroviral therapy: a swinging pendulum?
Gallant JE
Top HIV Med; 2008; 16(2):82-8. PubMed ID: 18591715
[TBL] [Abstract][Full Text] [Related]
8. Long-term immunological outcomes in treated HIV-infected individuals in high-income and low-middle income countries.
Achhra AC; Phanuphak P; Amin J
Curr Opin HIV AIDS; 2011 Jul; 6(4):258-65. PubMed ID: 21546834
[TBL] [Abstract][Full Text] [Related]
9. When and why to start antiretroviral therapy?
Gatell JM
J Antimicrob Chemother; 2010 Mar; 65(3):383-5. PubMed ID: 20071369
[TBL] [Abstract][Full Text] [Related]
10. Improvements in antiretroviral therapy outcomes over calendar time.
Boyd MA
Curr Opin HIV AIDS; 2009 May; 4(3):194-9. PubMed ID: 19532050
[TBL] [Abstract][Full Text] [Related]
11. Should HIV therapy be started at a CD4 cell count above 350 cells/microl in asymptomatic HIV-1-infected patients?
Sabin CA; Phillips AN
Curr Opin Infect Dis; 2009 Apr; 22(2):191-7. PubMed ID: 19283914
[TBL] [Abstract][Full Text] [Related]
12. Early treatment of HIV: implications for resource-limited settings.
Hobbs CV; Essajee SM
Curr Opin HIV AIDS; 2009 May; 4(3):222-31. PubMed ID: 19532054
[TBL] [Abstract][Full Text] [Related]
13. Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
Vogel M; Rockstroh JK
Curr Opin HIV AIDS; 2009 May; 4(3):171-5. PubMed ID: 19532046
[TBL] [Abstract][Full Text] [Related]
14. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study.
Sogaard OS; Lohse N; Gerstoft J; Kronborg G; Ostergaard L; Pedersen C; Pedersen G; Sørensen HT; Obel N
Clin Infect Dis; 2008 Nov; 47(10):1345-53. PubMed ID: 18834317
[TBL] [Abstract][Full Text] [Related]
15. Modeling CD4+ cell count increase over a six-year period in HIV-1-infected patients on highly active antiretroviral therapy in Senegal.
De Beaudrap P; Etard JF; Diouf A; Ndiaye I; Guèye NF; Guèye PM; Sow PS; Mboup S; Ndoye I; Ecochard R; Eric D;
Am J Trop Med Hyg; 2009 Jun; 80(6):1047-53. PubMed ID: 19478274
[TBL] [Abstract][Full Text] [Related]
16. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation.
Molina-Pinelo S; Vallejo A; Díaz L; Soriano-Sarabia N; Ferrando-Martínez S; Resino S; Muñoz-Fernández MA; Leal M
J Antimicrob Chemother; 2009 Sep; 64(3):579-88. PubMed ID: 19608579
[TBL] [Abstract][Full Text] [Related]
17. Potential impact of early antiretroviral therapy on transmission.
Pao D; Pillay D; Fisher M
Curr Opin HIV AIDS; 2009 May; 4(3):215-21. PubMed ID: 19532053
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral effects on HIV-1 RNA, CD4 cell count and progression to AIDS or death: a meta-regression analysis.
Mills EJ; Kelly S; Bradley M; Mollon P; Cooper C; Nachega J
HIV Med; 2008 Nov; 9(10):849-57. PubMed ID: 18795965
[TBL] [Abstract][Full Text] [Related]
19. HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy.
Kolte L; Ryder LP; Albrecht-Beste E; Jensen FK; Nielsen SD
Scand J Immunol; 2009 Dec; 70(6):608-13. PubMed ID: 19906203
[TBL] [Abstract][Full Text] [Related]
20. Predicting the potential benefits of early initiation of ART: time to do a trial to find out.
Phillips AN; Emery S
Curr Opin HIV AIDS; 2009 May; 4(3):165-6. PubMed ID: 19532044
[No Abstract] [Full Text] [Related]
[Next] [New Search]
